How big is the Small Molecule Drug Discovery Market?

The Small Molecule Drug Discovery Market size is expected to reach USD 56.94 billion in 2024 and grow at a CAGR of 8.76% to reach USD 86.65 billion by 2029. Read More

What is the current Small Molecule Drug Discovery Market size?

In 2024, the Small Molecule Drug Discovery Market size is expected to reach USD 56.94 billion. Read More

Who are the key players in Small Molecule Drug Discovery Market?

ICON Plc, Thermo Fisher Scientific Inc., Eurofins Discovery, Charles River Laboratories. and Labcorp Drug Development are the major companies operating in the Small Molecule Drug Discovery Market. Read More

Which is the fastest growing region in Small Molecule Drug Discovery Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Small Molecule Drug Discovery Market?

In 2024, the North America accounts for the largest market share in Small Molecule Drug Discovery Market. Read More

What years does this Small Molecule Drug Discovery Market cover, and what was the market size in 2023?

In 2023, the Small Molecule Drug Discovery Market size was estimated at USD 51.95 billion. The report covers the Small Molecule Drug Discovery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Small Molecule Drug Discovery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Small Molecule Drug Discovery Market Share

Statistics for the 2023 & 2024 Small Molecule Drug Discovery market share, created by Mordor Intelligence™ Industry Reports. Small Molecule Drug Discovery share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Small Molecule Drug Discovery Industry

The small-molecule drug discovery market is moderately competitive due to the presence of a few companies operating globally as well as regionally. Major companies have undertaken several business strategies to gain a competitive edge, such as regional expansion, mergers and acquisitions, and collaborative research initiatives. Some of the key players in the market are ICON PLC, Charles River Laboratories, Labcorp Drug Development, Thermo Fisher Scientific Inc., and Eurofins Discovery.